Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Umbilical cord blood transplantation may allow doctors to give higher doses of
chemotherapy or radiation therapy and kill more cancer cells.
PURPOSE: This phase II trial is studying how well umbilical cord blood transplantation works
in treating patients with severe aplastic anemia, malignant thymoma, or myelodysplasia.